Evidence map›Paper›PMID 41337470›Full record

ArticlePLoS computational biology2025

BAGEL: Protein engineering via exploration of an energy landscape.

Jakub Lála, Ayham Al-Saffar, Stefano Angioletti-Uberti

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Validation and analysis of 12,000 AI-driven CAR-T designs in thebioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jakub LálaDepartment of Materials, Imperial College London, London, United Kingdom.ORCID 0000-0002-5424-5260
Ayham Al-SaffarDepartment of Materials, Imperial College London, London, United Kingdom.ORCID 0009-0007-9772-8610
Stefano Angioletti-UbertiDepartment of Materials, Imperial College London, London, United Kingdom.ORCID 0000-0003-2917-2415

Funding

UK Materials and Molecular Modelling Hub EP/P020194/1UK Materials and Molecular Modelling Hub EP/T022213/1UK Materials and Molecular Modelling Hub EP/W032260/1
6 · The paper itself

Abstract

Despite recent breakthroughs in deep learning methods for protein design, existing computational pipelines remain rigid, highly specific, and ill-suited for tasks requiring non-differentiable or multi-objective design goals. In this report, we introduce BAGEL, a modular, open-source framework for programmable protein engineering, enabling flexible exploration of sequence space through model-agnostic and gradient-free exploration of an energy landscape. BAGEL formalizes protein design as the sampling of an energy function, either to optimize (find a global optimum) or to explore a basin of interest (generate diverse candidates). This energy function is composed of user-defined terms capturing geometric constraints, sequence embedding similarities, or structural confidence metrics. BAGEL also natively supports multi-state optimization and advanced Monte Carlo techniques, providing researchers with a flexible alternative to fixed-backbone and inverse-folding paradigms common in current design workflows. Moreover, the package seamlessly integrates a wide range of publicly available deep learning protein models, allowing users to rapidly take full advantage of any future improvements in model accuracy and speed. We illustrate the versatility of BAGEL on four archetypal applications: designing de novo peptide binders, targeting intrinsically disordered epitopes, selectively binding to species-specific variants, and generating enzyme variants with conserved catalytic sites. By offering a modular, easy-to-use platform to define custom protein design objectives and optimization strategies, BAGEL aims to speed up the design of new proteins. Our goal with its release is to democratize protein design, abstracting the process as much as possible from technical implementation details and thereby making it more accessible to the broader scientific community, unlocking untapped potential for innovation in biotechnology and therapeutics.

Indexed as

Protein EngineeringProteinsSoftwareComputational BiologyDeep LearningModels, MolecularMonte Carlo MethodProteins

Identifiers

PMID41337470
PMCPMC12688157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.